These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 6459863)

  • 21. [Cytotoxic properties of anti-kidney antibodies in the chick embryo. I--Antibodies reacting with an antigen specific for the proximal segment of the secretory tubules].
    Goicoechea O; Croisille Y
    Arch Anat Microsc Morphol Exp; 1984; 73(2):91-103. PubMed ID: 6517591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoclonal anti-idiotype antibody bearing the internal image of nasopharyngeal carcinoma associated antigen.
    Li G; Hu J; Zhou G; Zhu J; Sun Q
    Chin Med J (Engl); 2001 Sep; 114(9):962-6. PubMed ID: 11780392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mapping of binding epitopes of a human decay-accelerating factor monoclonal antibody capable of enhancing rituximab-mediated complement-dependent cytotoxicity.
    Guo B; Ma ZW; Li H; Xu GL; Zheng P; Zhu B; Wu YZ; Zou Q
    Clin Immunol; 2008 Aug; 128(2):155-63. PubMed ID: 18502181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relation between neutralization of Epstein-Barr virus and antibodies to cell-membrane antigens-induced by the virus.
    Pearson G; Dewey F; Klein G; Henle G; Henle W
    J Natl Cancer Inst; 1970 Nov; 45(5):989-95. PubMed ID: 18605425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trypanosoma cruzi: immunological consequences of parasite modification of host cells.
    Ribeiro Dos Santos R; Hudson L
    Clin Exp Immunol; 1980 Apr; 40(1):36-41. PubMed ID: 6771080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Colony inhibition test (C.I.T.) and the cytotoxic adherence test (C.A.T.): some comparative data].
    Pitzurra M; Marconi P; Iorio A; Bistoni F
    Ann Sclavo; 1971; 13(1):9-19. PubMed ID: 4340979
    [No Abstract]   [Full Text] [Related]  

  • 27. Development of solid phase antigen for indirect ELISA for the detection of specific antibody responses to infection with Newcastle disease virus.
    Sahle M; Burgess GW
    Onderstepoort J Vet Res; 2002 Sep; 69(3):237-42. PubMed ID: 12356171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Demonstration of natural antibodies in normal rabbit serum with similar specificity pattern as mouse natural killer cells.
    Grönberg A; Hansson M; Kiessling R; Andersson B; Kärre K; Roder J
    J Natl Cancer Inst; 1980 May; 64(5):1113-9. PubMed ID: 6966004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis B virus sensitizes hepatocytes to complement-dependent cytotoxicity through downregulating CD59.
    Qu Z; Liang X; Liu Y; Du J; Liu S; Sun W
    Mol Immunol; 2009 Dec; 47(2-3):283-9. PubMed ID: 19804910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition or enhancement of immunological injury of virus-infected cells.
    Brier AM; Wohlenberg C; Rosenthal J; Mage M; Notkins AL
    Proc Natl Acad Sci U S A; 1971 Dec; 68(12):3073-7. PubMed ID: 5316196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro treatment of human acute lymphocytic leukemia cells in bone marrow with a cocktail of monoclonal antibodies.
    Nakamura H; Hirayama F; Tatsumi Y; Tani Y; Kubota Y; Kanakura Y; Oguma S; Ueda T; Shibata H; Masaoka T
    Jpn J Clin Oncol; 1984 Dec; 14 Suppl 1():537-42. PubMed ID: 6596454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental infection of calves with Newcastle disease virus induces systemic and mucosal antibody responses.
    Subbiah M; Yan Y; Rockemann D; Samal SK
    Arch Virol; 2008; 153(6):1197-200. PubMed ID: 18478179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD46 (MCP) confers protection from lysis by xenogeneic antibodies.
    Loveland BE; Johnstone RW; Russell SM; Thorley BR; McKenzie IF
    Transplant Proc; 1993 Feb; 25(1 Pt 1):396-7. PubMed ID: 8438351
    [No Abstract]   [Full Text] [Related]  

  • 34. Hyperthermia enhancement of antibody-complement cytotoxicity for human colon tumor cells.
    Tompkins WA; Rama Rao GV; Pantasatos P; Cain CA
    J Natl Cancer Inst; 1981 Mar; 66(3):453-9. PubMed ID: 6937702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective immunity against Newcastle disease: the role of antibodies specific to Newcastle disease virus polypeptides.
    Reynolds DL; Maraqa AD
    Avian Dis; 2000; 44(1):138-44. PubMed ID: 10737654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of complement and gp120-specific antibodies in virus lysis and CD4+ T cell depletion in HIV-1-infected patients.
    Gerencer M; Burek V; Crowe BA; Barrett NP; Dorner F
    Microb Pathog; 1998 Nov; 25(5):253-66. PubMed ID: 9878454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specific lysis of Plasmodium yoelii infected mouse erythrocytes with antibody and complement.
    Gabriel J; Berzins K
    Clin Exp Immunol; 1983 Apr; 52(1):129-34. PubMed ID: 6861370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tolerance following immunity, with loss of serum specificity, in adult rabbits injected repeatedly with HeLa cells.
    Miller GL
    J Immunol; 1971 Jun; 106(6):1654-9. PubMed ID: 5519085
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies on the ability of monoclonal antibodies to selectively mediate complement-dependent cytotoxicity of human myelogenous leukemia blast cells.
    Ball ED; Kadushin JM; Schacter B; Fanger MW
    J Immunol; 1982 Mar; 128(3):1476-81. PubMed ID: 6948897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sodium butyrate affects expression of fibronectin on CHO cells: specific increase in antibody-complement-mediated cytotoxicity.
    Milhaud P; Yamada KM; Gottesman MM
    J Cell Physiol; 1980 Aug; 104(2):163-70. PubMed ID: 7410488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.